Mitesh

/Mitesh

About Mitesh

This author has not yet filled in any details.
So far Mitesh has created 299 blog entries.

Company Led Recall: Nutramigen® LGG Stage 1 & 2 Hypoallergenic Formula – Reckitt Benckiser Healthcare (UK) Ltd

Date issued: 3 January 2024 The Food Standards Agency has issued a company-led medicines recall for: Nutramigen® LGG Stage 1 & 2 Hypoallergenic Formula – Reckitt Benckiser Healthcare (UK) Ltd Company name: Reckitt Benckiser Healthcare (UK) Ltd Product name: Nutramigen® LGG Stage 1 & 2 Hypoallergenic Formula Batch number/expiry Product name Batch number Expiry date [...]

The post Company Led Recall: Nutramigen® LGG Stage 1 & 2 Hypoallergenic Formula – Reckitt Benckiser Healthcare (UK) Ltd appeared first on Community Pharmacy England.

By |January 5th, 2024|Lexpos News|Comments Off on Company Led Recall: Nutramigen® LGG Stage 1 & 2 Hypoallergenic Formula – Reckitt Benckiser Healthcare (UK) Ltd

Reminder: Submit your EPS claims by 5 January and FP34Cs by 6 January

To avoid any delays in payment for electronic prescriptions dispensed in December (Dispense Notification messages submitted by 31 December 2023), pharmacy owners are reminded to submit their corresponding electronic Claim Notification (CN) messages or Electronic Reimbursement Endorsement Messages (EREMs) no later than the 5 January 2024. However, with New Year’s Day (1 January 2024) occurring [...]

The post Reminder: Submit your EPS claims by 5 January and FP34Cs by 6 January appeared first on Community Pharmacy England.

By |January 4th, 2024|Lexpos News|Comments Off on Reminder: Submit your EPS claims by 5 January and FP34Cs by 6 January

Class 4 Medicines Defect Information: Cozaar® 100mg film-coated tablets (Quadrant Pharmaceuticals Ltd)

Class 4 Medicines Defect Information: Cozaar® 100mg film-coated tablets (Quadrant Pharmaceuticals Ltd) Drug alert number: EL (24)A/01 Date issued: 04 January 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Cozaar® 100mg film-coated tablets (Quadrant Pharmaceuticals Ltd) Company name: Quadrant Pharmaceuticals Ltd Product name: Cozaar® [...]

The post Class 4 Medicines Defect Information: Cozaar® 100mg film-coated tablets (Quadrant Pharmaceuticals Ltd) appeared first on Community Pharmacy England.

By |January 4th, 2024|Lexpos News|Comments Off on Class 4 Medicines Defect Information: Cozaar® 100mg film-coated tablets (Quadrant Pharmaceuticals Ltd)

December 2023 Price Concessions 3rd and Final Update

The 3rd price concession update published below on 22 December 2023 is the final update for the month. There are no further price concessions to announce for the month of December. However, Community Pharmacy England has queried some of prices imposed by DHSC and we are currently awaiting their response. If granted, any price adjustments [...]

The post December 2023 Price Concessions 3rd and Final Update appeared first on Community Pharmacy England.

By |December 22nd, 2023|Lexpos News|Comments Off on December 2023 Price Concessions 3rd and Final Update

December 2023 Price Concessions 2nd Update

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (20/12/2023) announced the following list of price concessions for December 2023. Community Pharmacy England has received a large number of reports of products not available at their Drug [...]

The post December 2023 Price Concessions 2nd Update appeared first on Community Pharmacy England.

By |December 20th, 2023|Lexpos News|Comments Off on December 2023 Price Concessions 2nd Update